Veradermics Incorporated MANE
—
116.57
0.85
0.73%
as of 25 Sep
- Market cap
- $5.0B
- P/E
- 0.0×
Follow MANE
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+2 more quarters Free account |
— | 16.66 | 59.12 | 70.53 |
Net Debt/EBITDA |
0.00 | 0.00 | 13.09 | 27.74 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
— | — | 0.00 | 0.00 | |
Operating CF/Net income |
0.87 | 0.00 | 0.71 | 0.62 | |
Capex/Depreciation |
0.00 | 0.00 | — | 0.00 | |
Interest Coverage |
0.00 | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Free Cash Flow per Share |
(21.00) | 0.00 | (0.93) | (0.36) | |
Cash per Share |
0.00 | 0.00 | 17.21 | 20.28 | |
Shareholders Equity per Share |
0.00 | 0.00 | 17.21 | 20.12 | |
Interest Debt per Share |
0.00 | — | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 17.21 | 20.12 | |
Free Cash Flow |
(15.64) | (71.63) | (21.17) | (14.51) | |
Working Capital |
— | 143.34 | 390.35 | 813.05 | |
Capital Expenditures |
0.00 | (0.02) | — | (0.02) | |
Net Current Asset Value |
0.00 | (121.14) | 390.35 | 812.62 | |
| Other line items | |||||
Quick Ratio |
— | 15.50 | 58.19 | 70.11 | |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | |
Operating CF per Share |
(21.00) | 0.00 | (0.93) | (0.36) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Assets |
— | — | 226.45 | 412.87 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | — | 0.00% | 0.00% |
Columns are period end dates